Company: SMNR
Filing Date: 2025-06-11
Form Type: S-4/A
Source: 0001193125-25-139124
Chunk: 125

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-06-11
Form: S-4/A
Chunk 125
---
72 | % |
| Shares Underlying the Private Units    |     |               |     510,000 |     |   |  0.23 | % |     |                |     510,000 |     |   |  0.23 | % |     |                |     510,000 |     |   |  0.23 | % |     |                |     510,000 |     |   |  0.23 | % |     |                 |     510,000 |     |   |  0.23 | % |
| Scilex Holding Company (common)(5)     |     |               | 201,118,000 |     |   | 92.41 | % |     |                | 201,118,000 |     |   | 92.42 | % |     |                | 201,118,000 |     |   | 92.42 | % |     |                | 201,118,000 |     |   | 92.43 | % |     |                 | 201,118,000 |     |   | 92.43 | % |
| Scilex Holding Company (preferred)(6)  |     |               |   6,000,000 |     |   |  2.76 | % |     |                |   6,000,000 |     |   |  2.76 | % |     |                |   6,000,000 |     |   |  2.76 | % |     |                |   6,000,000 |     |   |  2.76 | % |     |                 |   6,000,000 |     |   |  2.76 | % |
| Consultant Fees Paid in Shares(7)      |     |               |   8,000,000 |     |   |  3.68 | % |     |                |   8,000,000 |     |   |  3.68 | % |     |                |   8,000,000 |     |   |  3.68 | % |     |                |   8,000,000 |     |   |  3.68 | % |     |                 |   8,000,000 |     |   |  3.68 | % |
| Den